Circulating active von Willebrand factor levels are increased in chronic kidney disease and end-stage renal disease.

van der Vorm, Lisa N; Visser, Ruben; Huskens, Dana; Veninga, Alicia; Adams, Denise L; Remijn, Jasper A; Hemker, Hendrik C; Rensma, Pieter L; van Horssen, Remco; de Laat, Bas

van der Vorm, Lisa N; Visser, Ruben; Huskens, Dana; Veninga, Alicia; Adams, Denise L; Remijn, Jasper A; Hemker, Hendrik C; Rensma, Pieter L; van Horssen, Remco; de Laat, Bas.

Afiliação

van der Vorm LN; Cardiovascular Research Institute Maastricht, Maastricht University Medical Centre, Maastricht, The Netherlands.
Visser R; Synapse Research Institute, Maastricht, The Netherlands.
Huskens D; Department of Clinical Chemistry and Hematology, Gelre Hospitals, Apeldoorn, The Netherlands.
Veninga A; Department of Nephrology, Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands.
Adams DL; Cardiovascular Research Institute Maastricht, Maastricht University Medical Centre, Maastricht, The Netherlands.
Remijn JA; Synapse Research Institute, Maastricht, The Netherlands.
Hemker HC; Synapse Research Institute, Maastricht, The Netherlands.
Rensma PL; Department of Nephrology, Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands.
van Horssen R; Cardiovascular Research Institute Maastricht, Maastricht University Medical Centre, Maastricht, The Netherlands.
de Laat B; Department of Clinical Chemistry and Hematology, Gelre Hospitals, Apeldoorn, The Netherlands.

Clin Kidney J ; 13(1): 72-74, 2020 Feb.

Article em En | MEDLINE | ID: mdl-32082555

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Clin Kidney J Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Holanda

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google